Experience

Camena Bioscience
• United Kingdom
• Biotechnology Research
• 1 - 100 Employee
• Senior Scientist

  • Sep 2023 - Present


University of Cambridge

• United Kingdom
• Research Services
• 700 & Above Employee

• Guest Lecturer

  • May 2019 - Present

  Lecturing 'Analysis of single cell RNA-seq data'. In this course we will be surveying the existing problems as well as the available computational and statistical frameworks available for the analysis of scRNA-seq. Lecturing 'Analysis of single cell RNA-seq data'. In this course we will be surveying the existing problems as well as the available computational and statistical frameworks available for the analysis of scRNA-seq.



Alloy Therapeutics, Inc

• United States
• Biotechnology Research
• 1 - 100 Employee

• Molecular Biology Scientist

  • Feb 2021 - Sep 2023

  Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together.

• Associate Scientist

  • Jan 2020 - Jan 2021



Wellcome Sanger Institute

• United Kingdom
• Research Services
• 700 & Above Employee

• Visiting Scientist

  • Jan 2020 - Sep 2020

• Postdoctoral Fellow

  • Jan 2017 - Dec 2019

  In the Dr Gaffney’s group, we combine computational and statistical methods with high-throughput experimental techniques to understand the role played by changes in gene regulation in disease susceptibility and human evolution.



Open Targets

• United Kingdom
• Research
• 1 - 100 Employee

• Postdoctoral Fellow

  • Jan 2017 - Dec 2019

  The objective of this role is to develop and optimize a protocol for the generation of iPS cell-derived dendritic cells, characterise these cells at phenotypic, functional and molecular levels, develop and execute CRISPR–Cas9 based screens in these cells to identify immune-modulatory targets, and validate putative targets in iPS-cell-derived and primary dendritic cells. The objective of this role is to develop and optimize a protocol for the generation of iPS cell-derived dendritic cells, characterise these cells at phenotypic, functional and molecular levels, develop and execute CRISPR–Cas9 based screens in these cells to identify immune-modulatory targets, and validate putative targets in iPS-cell-derived and primary dendritic cells.



Aarhus University (Denmark)

• Mental Health Care
• 1 - 100 Employee

• PhD Student

  • Sep 2012 - Mar 2017

  As a PhD-student, I was involved in: Research, process-optimisation, project management, supervision, developing teaching material and teaching laboratory courses

• Research Assistant at the Department of Biomedicine

  • Jan 2012 - Aug 2012